Modulation of TLR4 signaling pathway
Hauptforschende*r
Prof. Dr. Antje Ostareck-Lederer
Forschungsinstitut
Universitätsklinikum RWTH Aachen
Abstract
The present invention relates to compounds for use in modulating the toll-like receptor 4 (TLR4) signaling pathway, as well as to a pharmaceutical composition comprising said compounds.
Fördersumme
30.000 Euro (2014)